Combination of rituximab and abatacept as an exit strategy for repetitive B-cell depletion in children with severe autoimmune diseases: a report of three cases

Lupus. 2018 Oct;27(12):1996-1998. doi: 10.1177/0961203318783057. Epub 2018 Jun 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abatacept / therapeutic use*
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology*
  • Child
  • Female
  • Humans
  • Rituximab / therapeutic use*
  • Treatment Outcome

Substances

  • Rituximab
  • Abatacept